157 related articles for article (PubMed ID: 16410971)
21. [Susceptibility of Aedes aegypti (L.) strains from Havana to a Bacillus thuringiensis var. israelensis].
Menéndez Díaz Z; Rodríguez Rodríguez J; Gato Armas R; Companioni Ibañez A; Díaz Pérez M; Bruzón Aguila RY
Rev Cubana Med Trop; 2012; 64(3):324-9. PubMed ID: 23424808
[TBL] [Abstract][Full Text] [Related]
22. Isolation of mosquito-pathogenic Bacillus sphaericus & B. thuringiensis from the root surface of hydrophytes.
Manonmani AM; Rajendran G; Balaraman K
Indian J Med Res; 1991 Mar; 93():111-4. PubMed ID: 1855819
[TBL] [Abstract][Full Text] [Related]
23. Laboratory and field evaluation of Bacillus thuringiensis and B. sphaericus against mosquito larvae.
Baruah I; Das SC
J Commun Dis; 1994 Jun; 26(2):82-7. PubMed ID: 7989680
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of Czechoslovak and Soviet Bacillus thuringiensis (serotype H-14) formulations against mosquito larvae.
Rettich F
J Hyg Epidemiol Microbiol Immunol; 1987; 31(1):53-63. PubMed ID: 2883232
[TBL] [Abstract][Full Text] [Related]
25. [Control of Simuliidae with an emulsifiable concentrate of Bacillus thuringiensis].
Araújo-Coutinho CJ; Lacey LA
Bol Oficina Sanit Panam; 1990 Mar; 108(3):213-9. PubMed ID: 2143072
[TBL] [Abstract][Full Text] [Related]
26. Strain of Bacillus thuringiensis from Restinga, toxic to Aedes (Stegomyia) aegypti (Linnaeus) (Diptera, Culicidae).
Vieira-Neta MRA; Soares-da-Silva J; Viana JL; Silva MC; Tadei WP; Pinheiro VCS
Braz J Biol; 2021; 81(4):872-880. PubMed ID: 33053121
[TBL] [Abstract][Full Text] [Related]
27. Phenotypic and genotypic features of new autoagglutinating Bacillus thuringiensis strains.
Chaves JQ; Cavados CF; Rabinovitch L
J Invertebr Pathol; 2008 May; 98(1):85-92. PubMed ID: 18304571
[TBL] [Abstract][Full Text] [Related]
28. [Experimental observation of toxic effect of Bacillus thuringiensis var. israelensis against Aedes, Culex and Anopheles larvae].
Li JL; Zhu GD; Zhou HY; Tang JX; Cao J
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2014 Feb; 26(1):67-8. PubMed ID: 24800571
[TBL] [Abstract][Full Text] [Related]
29. Laboratory evaluation of Bacillus thuringiensis H-14 against Aedes aegypti larvae in the northeast region of Thailand.
Pipitgool V; Maleewong W; Daenseegaew W; Thaiklar K
Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):426-8. PubMed ID: 1818396
[TBL] [Abstract][Full Text] [Related]
30. Larvicidal activity of the entomopathogenic fungus Tolypocladium cylindrosporum (Deuteromycotina: Hyphomycetes) on the mosquito Aedes triseriatus and the black fly Simulium vittatum (Diptera: Simuliidae).
Nadeau MP; Boisvert JL
J Am Mosq Control Assoc; 1994 Dec; 10(4):487-91. PubMed ID: 7707051
[TBL] [Abstract][Full Text] [Related]
31. Laboratory and semi-field evaluation of Mosquito Dunks against Aedes aegypti and Aedes albopictus larvae (Diptera: Culicidae).
Fansiri T; Thavara U; Tawatsin A; Krasaesub S; Sithiprasasna R
Southeast Asian J Trop Med Public Health; 2006 Jan; 37(1):62-6. PubMed ID: 16771214
[TBL] [Abstract][Full Text] [Related]
32. [Toxicity of Bacillus thuringiensis var. israelensis for Simulium larvae, vectors of onchocerciasis].
Guillet P; de Barjac H
C R Seances Acad Sci D; 1979 Oct; 289(6):549-52. PubMed ID: 118818
[TBL] [Abstract][Full Text] [Related]
33. Co-expression of Bacillus thuringiensis Cry4Ba and Cyt2Aa2 in Escherichia coli revealed high synergism against Aedes aegypti and Culex quinquefasciatus larvae.
Promdonkoy B; Promdonkoy P; Panyim S
FEMS Microbiol Lett; 2005 Nov; 252(1):121-6. PubMed ID: 16168580
[TBL] [Abstract][Full Text] [Related]
34. Susceptibility of laboratory and field-collected Aedes aegypti and Aedes albopictus to Bacillus thuringiensis israelensis H-14.
Lee YW; Zairi J
J Am Mosq Control Assoc; 2006 Mar; 22(1):97-101. PubMed ID: 16646329
[TBL] [Abstract][Full Text] [Related]
35. Relative activity of Bacillus thuringiensis var. kurstaki and B. thuringiensis var. israelensis against larvae of Aedes aegypti, Culex quinquefasciatus, trichoplusia ni, Heliothis zea, and Heliothis virescens.
Ignoffo CM; Couch TL; Garcia C; Kroha MJ
J Econ Entomol; 1981 Apr; 74(2):218-22. PubMed ID: 7320315
[No Abstract] [Full Text] [Related]
36. Laboratory evaluation of biotic and abiotic factors that may influence larvicidal activity of Bacillus thuringiensis serovar. israelensis against two Florida mosquito species.
Nayar JK; Knight JW; Ali A; Carlson DB; O'Bryan PD
J Am Mosq Control Assoc; 1999 Mar; 15(1):32-42. PubMed ID: 10342266
[TBL] [Abstract][Full Text] [Related]
37. Residual effect of two Bacillus thuringiensis var. israelensis products assayed against Aedes aegypti (Diptera: Culicidae) in laboratory and outdoors at Rio de Janeiro, Brazil.
Lima JB; de Melo NV; Valle D
Rev Inst Med Trop Sao Paulo; 2005; 47(3):125-30. PubMed ID: 16021284
[TBL] [Abstract][Full Text] [Related]
38. Isolation and characterization of Bacillus thuringiensis strains from aquatic environments in Spain.
Iriarte J; Porcar M; Lecadet M; Caballero P
Curr Microbiol; 2000 Jun; 40(6):402-8. PubMed ID: 10827284
[TBL] [Abstract][Full Text] [Related]
39. Comparative bioassays of Bacillus thuringiensis H-14 formulations against four species of mosquitoes in Malaysia.
Foo AE; Yap HH
Southeast Asian J Trop Med Public Health; 1982 Jun; 13(2):206-10. PubMed ID: 6128794
[TBL] [Abstract][Full Text] [Related]
40. WDP formulations using a novel mosquitocidal bacteria, Bacillus thuringiensis subsp. israelensis/tochigiensis (VCRC B-474) - Development and storage stability.
Shankar K; Prabakaran G; Manonmani AM
Acta Trop; 2019 May; 193():158-162. PubMed ID: 30562476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
